Executive Summary
|
Requestor | PI | Affiliation | Studies | Request Type | Request Date |
---|
A2ALL | 11 |
AALF | 3 |
AASK Cohort | 26 |
AASK Trial | 40 |
ALTOLD | 9 |
APRON123 | 1 |
ASSESS-AKI | 4 |
ATN | 17 |
BACH | 9 |
BARC | 1 |
BASE | 1 |
BetaFat | 1 |
CDS | 3 |
CKD Biocon | 1 |
CKiD | 24 |
CORI | 18 |
CPCRN2 RCT#1 | 1 |
CPCRN2 RCT#2 | 1 |
CPCRN Cohort | 1 |
CPCRN RCT #1 | 1 |
CRIC | 90 |
CRISP | 22 |
CUTIE | 6 |
CyNCh | 4 |
DAC | 4 |
DCCT/EDIC | 85 |
DILIN Pro | 1 |
DILIN Retro | 1 |
DPP | 70 |
DPPOS | 37 |
DPT-1 | 19 |
FAVORIT | 5 |
FDTT | 1 |
FHN Daily | 9 |
FHN Nocturnal | 5 |
FIND | 1 |
FLINT | 12 |
FONT II | 1 |
FSGS/FONT | 4 |
GoKinD | 14 |
GpR | 1 |
GRAFT | 1 |
HALT-C | 18 |
HALT PKD | 12 |
HAPO-FUS | 1 |
HEALTHY | 6 |
HEMO | 28 |
ICDB | 7 |
LABS | 11 |
LOGIC | 1 |
Look AHEAD | 35 |
LTD/LTD2 | 10 |
LURN | 3 |
MAPP | 3 |
MDRD | 35 |
Metabolic Control Study | 3 |
MTOPS | 17 |
NAFLD Adult | 20 |
NAFLD Pediatric | 5 |
NASH | 3 |
NORIG | 1 |
PEDS-C | 2 |
PIVENS | 16 |
RIVUR | 7 |
SISTEr | 5 |
SPLIT | 1 |
T1DGC | 38 |
T1DGC-Special | 3 |
TEDDY | 37 |
Teen-LABS | 2 |
TiME | 1 |
TINSAL-T2D | 1 |
TN01 NH | 9 |
TN02 MMF/DZB | 9 |
TN05 antiCD20 | 13 |
TN06 NIP pilot | 2 |
TN07 Oral Insulin | 5 |
TN08 GAD new onset | 8 |
TN09 CTLA4-Ig | 9 |
TN10 Anti-CD3 Prevention | 5 |
TN14 Anti-IL-1 Beta | 9 |
TN16 LIFT | 3 |
TN19 ATG-GCSF | 6 |
TODAY | 5 |
TOMUS | 11 |
TONIC | 7 |
ValUE | 2 |
Virahep-C | 9 |